ClinVar Miner

Submissions for variant NM_003052.5(SLC34A1):c.398C>T (p.Ala133Val)

gnomAD frequency: 0.00298  dbSNP: rs148976897
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000358499 SCV000456670 likely benign Hypophosphatemic nephrolithiasis/osteoporosis 1 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Labcorp Genetics (formerly Invitae), Labcorp RCV000957594 SCV001104405 likely benign not provided 2024-01-29 criteria provided, single submitter clinical testing
GeneDx RCV000957594 SCV001779576 likely benign not provided 2021-03-22 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 16688119, 30778725, 31188746, 28893421, 26787776)
Fulgent Genetics, Fulgent Genetics RCV002488784 SCV002807329 likely benign Hypophosphatemic nephrolithiasis/osteoporosis 1; Fanconi renotubular syndrome 2; Hypercalcemia, infantile, 2 2022-04-15 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000957594 SCV004158107 likely benign not provided 2023-06-01 criteria provided, single submitter clinical testing SLC34A1: BS2
Breakthrough Genomics, Breakthrough Genomics RCV000957594 SCV005222564 likely benign not provided criteria provided, single submitter not provided
Yale Center for Mendelian Genomics, Yale University RCV000662331 SCV000784663 likely pathogenic Nephrocalcinosis 2017-09-08 no assertion criteria provided literature only
PreventionGenetics, part of Exact Sciences RCV004544659 SCV004771901 likely benign SLC34A1-related disorder 2020-10-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.